MRNA, PGEN Stocks Hit Multi-Year Highs — What’s Driving The Momentum Today?

Moderna (MRNA) and Precigen (PGEN) hit new milestones on Friday, as investors weighed fresh Wall Street commentary on the biotech companies’ cancer-focused therapies.MRNA shares gained 1.5% to their highest level since January 2023, while PGEN shares edged marginally lower after hitting over five-y…